Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity
Co-Administration Phase 2 study of bremelanotide with tirzepatide (GLP-1) to provide key information for melanocortin treatments of obesity Topline data expected by end of calendar year 2024 Additional studies under assessment for multiple metabolic …